HomeCompareTSVT vs VIG

TSVT vs VIG: Dividend Comparison 2026

TSVT yields 40.00% · VIG yields 1.64%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TSVT wins by $199.5K in total portfolio value
10 years
TSVT
TSVT
● Live price
40.00%
Share price
$5.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$231.9K
Annual income
$39,181.04
Full TSVT calculator →
VIG
Vanguard Dividend Appreciation ETF
● Live price
1.64%
Share price
$210.70
Annual div
$3.45
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$32.4K
Annual income
$179.15
Full VIG calculator →

Portfolio growth — TSVT vs VIG

📍 TSVT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTSVTVIG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TSVT + VIG cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TSVT pays
VIG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TSVT
Annual income on $10K today (after 15% tax)
$3,400.00/yr
After 10yr DRIP, annual income (after tax)
$33,303.88/yr
VIG
Annual income on $10K today (after 15% tax)
$139.33/yr
After 10yr DRIP, annual income (after tax)
$152.28/yr
At 15% tax rate, TSVT beats the other by $33,151.61/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TSVT + VIG for your $10,000?

TSVT: 50%VIG: 50%
100% VIG50/50100% TSVT
Portfolio after 10yr
$132.1K
Annual income
$19,680.10/yr
Blended yield
14.90%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on TSVT right now

TSVT
Analyst Ratings
4
Buy
6
Hold
Consensus: Hold
Price Target
$3.50
-30.0% upside vs current
Range: $2.00 — $5.00
Altman Z
-1.0
Piotroski
2/9
VIG
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TSVT buys
0
VIG buys
0
No recent congressional trades found for TSVT or VIG in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTSVTVIG
Forward yield40.00%1.64%
Annual dividend / share$2.00$3.45
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$231.9K$32.4K
Annual income after 10y$39,181.04$179.15
Total dividends collected$174.4K$1.7K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: TSVT vs VIG ($10,000, DRIP)

YearTSVT PortfolioTSVT Income/yrVIG PortfolioVIG Income/yrGap
1← crossover$14,700$4,000.00$11,304$163.92+$3.4KTSVT
2$21,224$5,495.33$12,759$166.33+$8.5KTSVT
3$30,125$7,415.26$14,382$168.52+$15.7KTSVT
4$42,071$9,836.48$16,192$170.52+$25.9KTSVT
5$57,854$12,838.17$18,210$172.34+$39.6KTSVT
6$78,403$16,499.54$20,460$173.98+$57.9KTSVT
7$104,788$20,897.28$22,968$175.48+$81.8KTSVT
8$138,226$26,102.79$25,763$176.83+$112.5KTSVT
9$180,082$32,179.61$28,878$178.05+$151.2KTSVT
10$231,869$39,181.04$32,350$179.15+$199.5KTSVT

TSVT vs VIG: Complete Analysis 2026

TSVTStock

2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.

Full TSVT Calculator →

VIGETF

Seeks to track the performance of the S&P U.S. Dividend Growers Index.Passively managed, full-replication approach.Fund remains fully invested.Large-cap equity, emphasizing stocks with a record of growing their dividends year over year.Low expenses minimize net tracking error.With respect to 75% of its total assets, the fund may not: (1) purchase more than 10% of the outstanding voting securities of any one issuer or (2) purchase securities of any issuer if, as a result, more than 5% of the fund’s total assets would be invested in that issuer’s securities; except as may be necessary to approximate the composition of its target index. This limitation does not apply to obligations of the U.S. government or its agencies or instrumentalities.

Full VIG Calculator →
📬

Get this TSVT vs VIG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TSVT vs SCHDTSVT vs JEPITSVT vs OTSVT vs KOTSVT vs MAINTSVT vs DGROTSVT vs NOBLTSVT vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.